ACCESSION: MSBNK-SMB_Measured-HSA015P0496000
RECORD_TITLE: Annotated; LysoPC(16:0); LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'EL03_pos_9873': {'bp': 1045491.0, 'sum': 4030010.0}, 'EL18_pos_9943': {'bp': 443484.0, 'sum': 1668046.0}, 'EL13_pos_9962': {'bp': 413936.0, 'sum': 1545303.0}, 'EL16_pos_9922': {'bp': 346720.0, 'sum': 1271022.0}, 'EL04_pos_9916': {'bp': 311529.0, 'sum': 1223743.0}, 'EL19_pos_10007': {'bp': 288431.0, 'sum': 1036437.0}, 'EL08_pos_9929': {'bp': 278696.0, 'sum': 1044718.0}, 'EL15_pos_9958': {'bp': 277412.0, 'sum': 1051800.0}, 'EL01_pos_9944': {'bp': 269406.0, 'sum': 1023332.0}, 'EL06_pos_9958': {'bp': 264577.0, 'sum': 1008058.0}, 'EL21_pos_9951': {'bp': 254892.0, 'sum': 939459.0}, 'EL02_pos_9999': {'bp': 252863.0, 'sum': 683547.0}, 'EL20_pos_9928': {'bp': 252780.0, 'sum': 954893.0}, 'EL14_pos_9973': {'bp': 225630.0, 'sum': 840809.0}, 'EL05_pos_9999': {'bp': 209118.0, 'sum': 806343.0}, 'EL09_pos_9935': {'bp': 193055.0, 'sum': 759721.0}, 'EL10_pos_9923': {'bp': 188340.0, 'sum': 682512.0}, 'EL12_pos_9977': {'bp': 187569.0, 'sum': 688177.0}, 'EL17_pos_9980': {'bp': 176188.0, 'sum': 664248.0}, 'EL07_pos_9933': {'bp': 163751.0, 'sum': 637225.0}, 'EL11_pos_9935': {'bp': 109375.0, 'sum': 419290.0}}
COMMENT: RETENTION_TIME_STDEV 0.021
COMMENT: PRECURSOR_M/Z_RAW 496.340097
COMMENT: PRECURSOR_M/Z_STDEV 0.000214
COMMENT: PRECURSOR_IN_MS1 mz 496.340011; int 52.870; delta(ppm) 0.762001
COMMENT: PROPOSED_CHARGE_STATE +1; mz 497.343430; int 14.095; cor 0.949
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.306; C31H45NO4; [M+H]+; delta(ppm) -4.306196
COMMENT: PROPOSED_MF SevenGoldenRules 2.219; C25H46N5O3P; [M+H]+; delta(ppm) -2.218711
COMMENT: PROPOSED_MF SevenGoldenRules 0.480; C24H50NO7P; [M+H]+; delta(ppm) 0.480485
COMMENT: PROPOSED_MF SevenGoldenRules 3.816; C26H45N3O6; [M+H]+; delta(ppm) 3.815617
COMMENT: PROPOSED_MF MS-FINDER 3.518; C24H50NO7P; [M+H]+; delta(ppm) 0.478728
COMMENT: PROPOSED_MF MS-FINDER 2.765; C27H41N7O2; [M+H]+; delta(ppm) 1.112070
COMMENT: PROPOSED_MF MS-FINDER 2.415; C17H50N7O5PS; [M+H]+; delta(ppm) -0.902986
COMMENT: PROPOSED_MF MS-FINDER 2.393; C31H45NO4; [M+H]+; delta(ppm) -4.298170
COMMENT: PROPOSED_MF MS-FINDER 2.248; C12H37N19O3; [M+H]+; delta(ppm) 0.099491
COMMENT: PROPOSED_MF MS-FINDER 2.240; C12H45N15O2S2; [M+H]+; delta(ppm) 1.043192
COMMENT: PROPOSED_MF MS-FINDER 2.206; C19H45N9O4S; [M+H]+; delta(ppm) 2.424912
COMMENT: PROPOSED_MF MS-FINDER 2.184; C25H46N5O3P; [M+H]+; delta(ppm) -2.215820
COMMENT: PROPOSED_MF MS-FINDER 2.138; C25H54NO2PS2; [M+H]+; delta(ppm) -1.272122
COMMENT: PROPOSED_MF MS-FINDER 2.098; C20H41N13S; [M+H]+; delta(ppm) -0.269646
COMMENT: PROPOSED_MF MS-FINDER 2.066; C27H49N3OS2; [M+H]+; delta(ppm) 2.055774
COMMENT: PROPOSED_MF MS-FINDER 2.062; C23H49N3O6S; [M+H]+; delta(ppm) -2.985342
COMMENT: PROPOSED_MF MS-FINDER 2.002; C19H53N5O3S3; [M+H]+; delta(ppm) 3.368618
COMMENT: PROPOSED_MF MS-FINDER 2.001; C26H45N3O6; [M+H]+; delta(ppm) 3.806636
COMMENT: PROPOSED_MF MS-FINDER 1.988; C13H46N13O3PS; [M+H]+; delta(ppm) 4.507291
COMMENT: PROPOSED_MF MS-FINDER 1.864; C16H49N9O4S2; [M+H]+; delta(ppm) -4.367047
COMMENT: PROPOSED_MF MS-FINDER 1.681; C19H61NO2S5; [M+H]+; delta(ppm) 4.312326
COMMENT: PROPOSED_MF MS-FINDER 1.658; C24H53N3OS3; [M+H]+; delta(ppm) -4.736180
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4070.831; C24H50NO7P; [M+H]+; delta(ppm) 0.478728
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C24H50NO7P; [M+H]+; delta(ppm) 0.478728
COMMENT: PROPOSED_MF SIRIUS6_Sirius 95.974; C24H50NO7P; [M+H]+; delta(ppm) 0.478728
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C24H50NO7P; [M+H]+; delta(ppm) 0.478728
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 8.000; ASWBNKHCZGQVJV-HSZRJFAPSA-N; C24H50NO7P; Spectral Match to Lyso-PC(16:0) from NIST14
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; ASWBNKHCZGQVJV-UHFFFAOYSA-N; C24H50NO7P; Massbank:RP012103 PC(16:0/0:0)Palmitoyllysolectithin(3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.300; HEALIQQDEGDSLS-XMMPIXPASA-N; [M+H]+; CCCCCCCCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.268; ASWBNKHCZGQVJV-HSZRJFAPSA-N; [M+H]+; CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.623; GEWUBFCXNZWHKH-QWVACARCNA-N; [M+H]+; CCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)COP(O)(=O)OCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.304; LUENCTUIABKZJY-SWTFBISJNA-N; [M+H]+; CC(C)=CCNC(=N)NCCC[C@@H]1NC2=C(C=C(C=C2)C(O)=O)[C@@H]2[C@H]1CCN2C(=N)NCC=C(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.266; HRIMUOJUPCUAIQ-UHFFFAOYSA-N; [M+H]+; O=C(OCCCCCCCCCCCCCC)C(NC(=O)CC=1C=CC=CC1)C(O)C=2C=CC=CC2
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.243; ASWBNKHCZGQVJV-HSZRJFAPSA-N; [M+H]+; LysoPC(16:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.658; HEALIQQDEGDSLS-XMMPIXPASA-N; [M+H]+; 1-tetradecyl-2-acetyl-sn-glycero-3-phosphocholine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.536; GEWUBFCXNZWHKH-QWVACARCNA-N; [M+H]+; PE(19:0/0:0)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.619; LUENCTUIABKZJY-SWTFBISJNA-N; [M+H]+; UNPD30923
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.110; ZZTXYUVDEDOUDW-GEPNPDQENA-N; [M+H]+; dysoxyhainanin A
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.036; IQVDATHRLIPXMF-FKULENCTNA-N; [M+H]+; UNPD200761
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.997; SUEGNJCEKLWPFO-UHFFFAOYSA-N; [M+H]+; 6-(1-acetyl-4-methylpyrrolidin-2-yl)-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0?,?.0?,?.0??,??]icosa-6,18-dien-16-yl acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.974; KESBUZBXJMXUNA-UHFFFAOYSA-N; [M+H]+; 5-(3-acetamido-2-methylpropyl)-7,9,13-trimethyl-6-oxopentacyclo[10.8.0.0?,?.0?,?.0??,??]icosa-4,18-dien-16-yl acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.959; HRIMUOJUPCUAIQ-UHFFFAOYSA-N; [M+H]+; tetradecyl 3-hydroxy-3-phenyl-2-(2-phenylacetamido)propanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.944; RFDKIHZDUCQJAN-UHFFFAOYSA-N; [M+H]+; 3-[({2-[4-(4-methoxyphenyl)-2,2-dimethyloxan-4-yl]ethyl}amino)methyl]-8a-methyl-5-methylidene-dodecahydronaphtho[2,3-b]furan-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.941; UFWINNDKPCZSNS-UHFFFAOYSA-N; [M+H]+; 3-[({2-[4-(4-methoxyphenyl)-2,2-dimethyloxan-4-yl]ethyl}amino)methyl]-5,8a-dimethyl-2H,3H,3aH,4H,6H,7H,8H,8aH,9H,9aH-naphtho[2,3-b]furan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KESBUZBXJMXUNA-UHFFFAOYSA-N; [M+H]+; 5-(3-acetamido-2-methylpropyl)-7,9,13-trimethyl-6-oxopentacyclo[10.8.0.0?,?.0?,?.0??,??]icosa-4,18-dien-16-yl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ASWBNKHCZGQVJV-HSZRJFAPSA-N; [M+H]+; LysoPC(16:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.961; HEALIQQDEGDSLS-XMMPIXPASA-N; [M+H]+; 1-tetradecyl-2-acetyl-sn-glycero-3-phosphocholine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.927; HRIMUOJUPCUAIQ-UHFFFAOYSA-N; [M+H]+; tetradecyl 3-hydroxy-3-phenyl-2-(2-phenylacetamido)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.924; IQVDATHRLIPXMF-FKULENCTNA-N; [M+H]+; UNPD200761
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.918; ZZTXYUVDEDOUDW-GEPNPDQENA-N; [M+H]+; dysoxyhainanin A
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.769; GEWUBFCXNZWHKH-QWVACARCNA-N; [M+H]+; PE(19:0/0:0)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.711; SUEGNJCEKLWPFO-UHFFFAOYSA-N; [M+H]+; 6-(1-acetyl-4-methylpyrrolidin-2-yl)-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0?,?.0?,?.0??,??]icosa-6,18-dien-16-yl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.663; UFWINNDKPCZSNS-UHFFFAOYSA-N; [M+H]+; 3-[({2-[4-(4-methoxyphenyl)-2,2-dimethyloxan-4-yl]ethyl}amino)methyl]-5,8a-dimethyl-2H,3H,3aH,4H,6H,7H,8H,8aH,9H,9aH-naphtho[2,3-b]furan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.663; RFDKIHZDUCQJAN-UHFFFAOYSA-N; [M+H]+; 3-[({2-[4-(4-methoxyphenyl)-2,2-dimethyloxan-4-yl]ethyl}amino)methyl]-8a-methyl-5-methylidene-dodecahydronaphtho[2,3-b]furan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; PUELOMOZSSTZTD-ZBCONREDSA-N; [M+H]+; N-[1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]heptadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; HCRQGMZYEJBFLQ-WLARPWFJSA-N; [M+H]+; (2R)-2-[(2S,6R,14R,15S,16R)-11-butoxy-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,18-tetraen-16-yl]-5-methylhexan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; UDPBJAJIZZTTJS-ZDXQCDESSA-N; [M+H]+; [(2S,3S,4R)-2-(hexanoylamino)-3,4-dihydroxyoctadecyl] dihydrogen phosphate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.743; JQPMTFFVLPKXFA-UHFFFAOYSA-N; [M+H]+; 2-[2-(butylcarbamoyloxy)ethyl-[2-(3-methoxy-2-propoxyphenyl)ethyl]amino]ethyl N-butylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -0.447; ASWBNKHCZGQVJV; [M+H]+; 1-16:0-lysoPC
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -56.784; GEWUBFCXNZWHKH; [M+H]+; 1-nonadecanoyl-glycero-3-phosphoethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -65.407; NEGQHKSYEYVFTD; [M+H]+; 2-palmitoyllysophosphatidylcholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -76.928; HEALIQQDEGDSLS; [M+H]+; 1-tetradecyl-2-acetyl-sn-glycero-3-phosphocholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.548; UDPBJAJIZZTTJS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.657; ASWBNKHCZGQVJV; [M+H]+; 1-16:0-lysoPC
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.769; ASWBNKHCZGQVJV; [M+H]+; 1-Palmitoyl-sn-glycero-3-phosphocholine-d9
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -208.613; HEALIQQDEGDSLS; [M+H]+; 1-Tetradecyl-2-acetyl-sn-glycero-3-phosphocholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -213.222; GEWUBFCXNZWHKH; [M+H]+; 1-Nonadecanoyl-glycero-3-phosphoethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -228.474; NEGQHKSYEYVFTD; [M+H]+; [(2S)-2-hexadecanoyloxy-3-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -363.684; UJJFIJULGLHVGP; [M+H]+; 1-(2-methoxy-6Z-octadecenyl)-sn-glycero-3-phosphoethanolamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -486.013; UDPBJAJIZZTTJS; [M+H]+; N-hexanoylphytosphingosine 1-phosphate(2-)
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.666; ASWBNKHCZGQVJV; [M+H]+; 1-Palmitoyl-sn-glycero-3-phosphocholine-d9
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match LysoPC(16:0), ASWBNKHCZGQVJV-HSZRJFAPSA-N; Matching to 8 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (1); This structural isomer was suggested from the biological context HMDB HMDB0010382;HMDB0062541;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C24H50NO7P
CH$EXACT_MASS: 495.332490
CH$SMILES: CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O
CH$IUPAC: InChI=1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m1/s1
CH$LINK: CHEBI CHEBI:28468
CH$LINK: HMDB HMDB0010382
CH$NAME: 1-Palmitoylglycerophosphocholine
CH$NAME: LysoPC(16:0)
CH$NAME: [(2R)-3-hexadecanoyloxy-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
CH$LINK: INCHIKEY ASWBNKHCZGQVJV-HSZRJFAPSA-N
CH$LINK: LIPIDMAPS LMGP01050018
CH$LINK: PUBCHEM CID:460602
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.199
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 496.340002
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0f89-3900100000-1b3d8add52df70b2e540
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0497205 12.4619 56.050433 1.0170 3.12 0.7893 15 f{C3H6N1}/4.37ppm,p-C21H45O7P1
  57.0701375 34.5708 57.070854 0.8586 5.16 0.8722 20 f{C4H9}/4.57ppm,p-C20H42N1O7P1
  58.0653557 12.5890 58.066076 1.3089 2.01 0.5357 15 f{C3H8N1}/3.96ppm,p-C21H43O7P1
  60.0810128 171.9949 60.081740 0.3828 18.28 0.9208 21 f{C3H10N1}/3.95ppm,p-C21H41O7P1
  71.0730801 60.9150 71.073823 0.8442 7.71 0.8870 21 f{C4H9N1}/1.82ppm,p-C20H42O7P1
  71.0856694 18.6856 71.086413 0.9847 4.69 0.7152 19 f{C5H11}/2.01ppm,p-C19H40N1O7P1
  86.0964672 479.7064 86.097174 0.2904 33.36 0.8896 21 f{C5H12N1}/0.48ppm,p-C19H39O7P1
  87.0998182 19.7907 87.100520 0.8381 3.30 0.8887 20 ?
  98.9841191 33.5344 98.984741 1.0507 4.65 0.8368 19 f{H4O4P1}/-0.51ppm,p-C24H47N1O3
  104.1070153 978.9740 104.107589 0.3170 124.64 0.9636 21 f{C5H14N1O1}/0.24ppm,p-C19H37O6P1
  105.1103071 38.1059 105.110871 1.3985 9.15 0.9429 20 ?
  124.9998483 257.0817 125.000238 0.4240 16.35 0.8818 21 f{C2H6O4P1}/0.23ppm,p-C22H45N1O3
  184.0733446 999.0000 184.073744 0.3151 23.88 0.8792 21 f{C5H15N1O4P1}/0.14ppm,p-C19H36O3
  185.0768801 41.4290 185.077282 1.2860 6.35 0.7156 21 ?
  478.3294504 97.7916 478.329916 1.3777 12.67 0.9325 21 f{C24H49N1O6P1}/0.52ppm,p-H2O1
  496.3401976 271.0424 496.340661 0.7193 40.26 1.0000 21 f{C24H51N1O7P1}/0.87ppm,p
  497.3434458 62.2345 497.343909 1.4236 11.46 0.8825 19 ?
PK$NUM_PEAK: 17
PK$PEAK: m/z int. rel.int.
  56.049720 12.46 12
  57.070138 34.57 34
  58.065356 12.59 12
  60.081013 171.99 171
  71.073080 60.91 60
  71.085669 18.69 18
  86.096467 479.71 479
  87.099818 19.79 19
  98.984119 33.53 33
  104.107015 978.97 978
  105.110307 38.11 38
  124.999848 257.08 257
  184.073345 999.00 999
  185.076880 41.43 41
  478.329450 97.79 97
  496.340198 271.04 271
  497.343446 62.23 62
//
